MSS/ MMRp

我们是谁

  • 12 月 8, 2022
    Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)
  • 12 月 8, 2022
    Evaluating Novel Therapies in ctDNA Positive GI Cancers
  • 12 月 8, 2022
    Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer
  • 12 月 8, 2022
    A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
  • 12 月 8, 2022
    Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer
  • 12 月 1, 2022
    Phase 2 Study of DKN-01 in Colorectal Cancer
  • 11 月 15, 2022
    Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer (STELLAR-303)
  • 9 月 19, 2022
    A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors
  • 9 月 19, 2022
    An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis
  • 7 月 26, 2022
    一项针对转移性结直肠癌晚期患者的 Nivolumab-relatlimab 固定剂量联合疗法对比瑞戈非尼或 TAS-102 的研究